Opthea Settles DFA Agreement, Averts $680M Liability and Announces Management Changes
PorAinvest
martes, 19 de agosto de 2025, 3:29 pm ET1 min de lectura
OPT--
Opthea's executive leadership has undergone significant changes. CEO Dr Fred Guerard, CFO Tom Reilly, and Director Sujal Shah will depart in September 2025. Dr Jeremy Levin will continue as Chairman and assume CEO responsibilities. The company has reduced its workforce by over 80% and its Board by over 50%.
The settlement represents a fundamental reset for Opthea. The remaining USD20 million provides limited runway for the company to conduct a strategic review over the next six months, considering internal development, partnerships, licensing opportunities, or potentially returning capital to shareholders. The settlement's legal protections, including 'springing liens,' demonstrate the precarious nature of the negotiated outcome.
Opthea's stock trading remains suspended by ASX, and the company will host a webcast on August 19 to discuss the settlement and future plans. Dr Jeremy Levin, who will continue as Chairman and assume additional responsibilities, expressed gratitude to the outgoing executive team and the DFA Investors for their collaboration.
References:
1. [https://www.stocktitan.net/news/OPT/opthea-provides-corporate-jomeqwei4c64.html](https://www.stocktitan.net/news/OPT/opthea-provides-corporate-jomeqwei4c64.html)
2. [https://www.reuters.com/sustainability/boards-policy-regulation/australias-opthea-announces-80-headcount-reduction-management-overhaul-2025-08-18/](https://www.reuters.com/sustainability/boards-policy-regulation/australias-opthea-announces-80-headcount-reduction-management-overhaul-2025-08-18/)
Opthea Limited has settled a Development Funding Agreement with DFA Investors, averting a potential $680m liability. The company will issue 9.99% of its shares to DFA Investors and retain $20m in cash reserves. Major management changes have been announced, including the resignation of CEO, CFO, and Director. Opthea will continue operations and conduct a strategic review to maximize shareholder value.
Opthea Limited (ASX/NASDAQ: OPT) has successfully reached a settlement with its Development Funding Agreement (DFA) investors, avoiding a potential USD680 million liability. The company will issue 136,661,003 shares (9.99% of its equity) to the investors and retain USD20 million in cash reserves. This settlement follows the failure of the COAST and ShORe phase 3 clinical trials for sozinibercept in wet AMD.Opthea's executive leadership has undergone significant changes. CEO Dr Fred Guerard, CFO Tom Reilly, and Director Sujal Shah will depart in September 2025. Dr Jeremy Levin will continue as Chairman and assume CEO responsibilities. The company has reduced its workforce by over 80% and its Board by over 50%.
The settlement represents a fundamental reset for Opthea. The remaining USD20 million provides limited runway for the company to conduct a strategic review over the next six months, considering internal development, partnerships, licensing opportunities, or potentially returning capital to shareholders. The settlement's legal protections, including 'springing liens,' demonstrate the precarious nature of the negotiated outcome.
Opthea's stock trading remains suspended by ASX, and the company will host a webcast on August 19 to discuss the settlement and future plans. Dr Jeremy Levin, who will continue as Chairman and assume additional responsibilities, expressed gratitude to the outgoing executive team and the DFA Investors for their collaboration.
References:
1. [https://www.stocktitan.net/news/OPT/opthea-provides-corporate-jomeqwei4c64.html](https://www.stocktitan.net/news/OPT/opthea-provides-corporate-jomeqwei4c64.html)
2. [https://www.reuters.com/sustainability/boards-policy-regulation/australias-opthea-announces-80-headcount-reduction-management-overhaul-2025-08-18/](https://www.reuters.com/sustainability/boards-policy-regulation/australias-opthea-announces-80-headcount-reduction-management-overhaul-2025-08-18/)

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios